Moderate riskFDA DrugClass II

GE Healthcare Omnipaque iohexol injection recalled for particulate matter

GE Healthcare has recalled specific lots of Omnipaque (iohexol) injection, a contrast dye used in medical imaging, because some vials may contain visible particles. This could affect the safety of the procedure if the contaminated solution is used.

From the FDA notice · Read the official notice ↗ · All GE Healthcare recalls

What to do

  1. If you work in a hospital or imaging facility, check your inventory against the 16 affected lot numbers listed in the recall notice
  2. Do not use any vials from the recalled lots, even if they appear clear to the eye
  3. Contact GE Healthcare or the FDA if you have questions about specific lot numbers

Is yours affected?

Compare your label or packaging with the recalled product.

Product
GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
866,570 vials
Illnesses reported
None reported
Manufactured in
Ida Business Park, Carrigtwohill, Ireland
Classification
Class II
Recall number
D-0447-2026

In the FDA's words

Description
GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63. Presence of particulate matter Lot# 17225029; Exp. September 3, 2028 Lot# 17265376; Exp. October 3, 2028 Lot# 17270885; Exp. September 10, 2028 Lot# 17292246; Exp. October 4, 2028 Lot# 17301805; Exp. October 18, 2028 Lot# 17301807; Exp. September 7, 2028 Lot# 17301810; Exp. October 20, 2028 Lot# 17304992; Exp. October 5, 2028 Lot# 17304993; Exp. October 19, 2028 Lot# 17304996; Exp. November 25, 2028 Lot# 17321225; Exp. September 8, 2028 Lot# 17333589; Exp. November 24, 2028 Lot# 17333611; Exp. November 26. 2028 Lot# 17333613; Exp. November 23. 2028 Lot# 17357000; Exp. December 5, 2028 Lot# 17366399; Exp. December 14, 2028 Lot# 17376486; Exp. December 14, 2028 Lot# 17404114; Exp. December 6, 2028 Distribution: U.S. Nationwide. Affected quantity: 866,570 vials
Hazard
Presence of particulate matter

2 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug